P05.02 A phase I/IIa dose escalation study evaluating the safety and efficacy of autologous CD34+ enriched hematopoietic progenitor cells genetically modified for human interferon-α2 in patients with GBM and an unmethylated MGMT promoter (TEM-GBM-001)

Details

Language :

English

ISSN :

15228517

Volume :

21

Database :

Complementary Index

Journal :

Neuro-Oncology

Publication Type :

Academic Journal

Accession number :

138503192

Full Text :

https://doi.org/10.1093/neuonc/noz126.116